-
Signature
-
/s/ Brennan McGreevy, Attorney in Fact
-
Stock symbol
-
ESS
-
Transactions as of
-
Aug 30, 2024
-
Transactions value $
-
-$165,523
-
Form type
-
4
-
Date filed
-
9/4/2024, 08:19 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ESS |
Common Stock |
Options Exercise |
$83.4K |
+370 |
+14.31% |
$225.44 |
2.96K |
Aug 30, 2024 |
Direct |
F1 |
| transaction |
ESS |
Common Stock |
Sale |
-$111K |
-370 |
-12.52% |
$300.00 |
2.59K |
Aug 30, 2024 |
Direct |
F1 |
| transaction |
ESS |
Common Stock |
Options Exercise |
$487K |
+2.08K |
+80.58% |
$233.78 |
4.67K |
Aug 30, 2024 |
Direct |
F1 |
| transaction |
ESS |
Common Stock |
Sale |
-$625K |
-2.08K |
-44.62% |
$300.00 |
2.59K |
Aug 30, 2024 |
Direct |
F1 |
| holding |
ESS |
Common Stock |
|
|
|
|
|
500 |
Aug 30, 2024 |
By Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ESS |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-370 |
-100% |
$0.00 |
0 |
Aug 30, 2024 |
Common Stock |
370 |
$225.44 |
Direct |
F1 |
| transaction |
ESS |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-2.08K |
-100% |
$0.00 |
0 |
Aug 30, 2024 |
Common Stock |
2.08K |
$233.78 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: